FDA — authorised 21 February 1978
- Marketing authorisation holder: FERRING PHARMS INC
- Status: approved
🇺🇸 Ddavp in United States
FDA authorised Ddavp on 21 February 1978
Marketing authorisations
FDA — authorised 21 February 1978
- Application: NDA017922
- Marketing authorisation holder: FERRING PHARMS INC
- Local brand name: DDAVP
- Indication: SPRAY, METERED — NASAL
- Status: approved
FDA — authorised 30 March 1984
- Application: NDA018938
- Marketing authorisation holder: NORDIC PHARMA
- Local brand name: DDAVP
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 6 September 1995
- Application: NDA019955
- Marketing authorisation holder: FERRING PHARMS INC
- Local brand name: DDAVP
- Indication: TABLET — ORAL
- Status: approved
Ddavp in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Ddavp approved in United States?
Yes. FDA authorised it on 21 February 1978; FDA authorised it on 21 February 1978; FDA authorised it on 30 March 1984.
Who is the marketing authorisation holder for Ddavp in United States?
FERRING PHARMS INC holds the US marketing authorisation.